HIV: Effectiveness of complementary and alternative medicine

Primary Care - Clinics in Office Practice

Volumn 29, Issue 2, 2002, Pages 361-378

  Power, Rachel ^a   Gore Felton, Cheryl ^b   Vosvick, Mark ^b   Israelski, Dennis M ^a,c   Spiegel, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c San Mateo Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CAPSAICIN; DRONABINOL; GARLIC EXTRACT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUPUNCTURE; ALTERNATIVE MEDICINE; CLINICAL FEATURE; CLINICAL TRIAL; HEALTH HAZARD; HERB; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASSAGE; PREVALENCE; PRIORITY JOURNAL; REVIEW; UNITED STATES; ATTITUDE TO HEALTH; DIET THERAPY; EXERCISE; FEMALE; MALE; METHODOLOGY; PATIENT PARTICIPATION; PATIENT SATISFACTION; PHYTOTHERAPY; QUALITY OF LIFE; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACUPUNCTURE; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; CLINICAL TRIALS; COMPLEMENTARY THERAPIES; EXERCISE; FEMALE; HIV INFECTIONS; HUMAN; MALE; MASSAGE; PATIENT PARTICIPATION; PATIENT SATISFACTION; PHYTOTHERAPY; QUALITY OF LIFE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME; UNITED STATES; HUMANS;

EID: 0036310353     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(01)00013-6     Document Type: Review

References (70)

1. Why do people choose and use complementary therapies?
2. Nine possible reasons for choosing complementary medicine
3. Complementary and alternative medicine in the management of pain, dyspnea and nausea and vomiting near the end of life: A systematic review
4. Freedom of choice: An issue concerning alternate therapies by patients with cancer
5. Alternative therapies used by patients with AIDS
6. Dealing with alternative therapies for HIV
7. HIV medicine: Drug side effects and interactions
8. Practical issues regarding the use of antiretroviral therapy for HIV infection
9. Complementary and alternative medicine and HIV-AIDS. Part II: Selected literature review
10. Factors associated with HIV-infected patients' recognition and use of HIV medications
11. Referrals for alternative therapies
12. Complementary medicine and HIV infection
13. Complementary and alternative therapies to manage HIV-related symptoms
14. Acupuncture and the opioid system: Implications in the management of migraine
15. Acupuncture modulates the limbic system and subcortical gray structures of the human brain: Evidence from fMRI studies in normal subjects
16. Symptom prevalence, characteristics, and distress in AIDS outpatients
17. Topical capsaicin in the management of HIV-associated peripheral neuropathy
18. Peripheral neuropathy associated with AIDS
19. Neurologic manifestations of HIV infection
20. A meta-analysis of acupuncture for chronic pain
21. Most frequently used alternative and complimentary therapies and activities by participants in the AMCOA study
22. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: A randomized controlled trial
23. How effective are complimentary therapies for HIV and AIDS? - A systematic review
24. Use of noninvasive electro-acupuncture for the treatment of HIV-related peripheral neuropathy: A pilot study
25. High prevalence of insomnia in an outpatient population with HIV infection
26. Effectiveness of acupuncture and attitude-relaxation in the treatment of primary sleep disorders
27. Acupuncture and insomnia
28. Effects of individualized acupuncture on sleep quality in HIV disease
29. Acupuncture ameliorates AIDS symptoms in 36 cases
30. Acupuncture for symptom relief in HIV-positive adults: Lessons learned from a pilot study
31. Complementary therapies and HIV infection
32. The use of alternative therapies for HIV infection: Implications for patient care
33. Massage therapy is associated with enhancement of the immune system's cytotoxic capacity
34. The effects of massage therapy alone in combination with other complementary therapies on immune system measures and quality of life in human immunodeficiency virus
35. Complementary therapy use among HIV-infected patients
36. Clinical trials update in human immunodeficiency virus wasting
37. Micronutrient supplementation in the AIDS diarrhoea-wasting syndrome in Zambia: A randomized controlled trial
38. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: A randomized, double-blind controlled trial
39. Complimentary and alternative medicine: A primer
40. Use of complimentary and alternative therapies in HIV-infected patients
41. Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms
42. Use of a Chinese herbal medicine for treatment of HIV-associated pathogen negative diarrhea
43. Post-herpetic neuralgia and topical capsaicin
44. Treatment of painful diabetic neuropathy with capsaicin 0.075%
45. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients
46. Treatment of HIV related weight loss
47. IOM finds scientific merit to medical marijuana
48. Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia
49. Effect of dronabinol on nutritional status in HIV infection
50. Dronabinol effects on weight in patients with HIV infection
51. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
52. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
53. Indinavir concentrations and St. John's wort
54. Garlic supplements decrease saquinavir plasma concentrations
55. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS
56. Revision if the CDC surveillance case definition for acquired immunodeficiency syndrome
57. Acquired immunodeficiency syndrome wasting, functional performance, and quality of life
58. Moderate and high intensity exercise training in HIV-1 seropositive individuals: A randomized trial
59. Change in CD4+ cell enumeration following aerobic exercise training in HIV-1 disease: Possible mechanisms and practical applications
60. The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients
61. Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons
62. Effects of exercise training on men seropositive for the human immunodeficiency virus-1
63. Progressive resistance exercise: Effect on muscle function and anthropometry of a select AIDS population
64. Exercise and the treatment of wasting: Aging and human immunodeficiency virus infection
65. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels
66. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting: A randomized, controlled trial
67. Aerobic exercise: Effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults
68. Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS: Improvements in affective and somatic symptoms
69. Use of alternative therapy among HIV-infected patients at an urban tertiary center